Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy

MYPI2025002482A0Undetermined Publication Date: 2017-10-15RES INST AT NATIONWIDE CHILDRENS HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002482
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-03-17
Filing Date
2017-04-14
Publication Date
2017-10-15
Patent Text Reader

Abstract

The invention provides for recombinant AAV vectors comprising a a miniaturized human micro-dystrophin gene and methods of using the recombinant vectors to reduce or prevent fibrosis in subjects suffering from muscular dystrophy. [Figure 1]
Need to check novelty before this filing date? Find Prior Art